Eighty-Seven Patient Groups Urge Congress to Pass Legislatio

Reauthorizing the Prescription Drug User Fee Act Would Make It Easier to Participate in Clinical Trials and Allow the FDA to Continue Its Critical Mission 

Related Keywords

United States , Washington , American , Katie Berge , Lisa Lacasse , Leukemia Lymphoma Society , Us House Energy , Commerce Committee , Drug Administration , Congress Do , Congressional Hispanic Caucus Institute Annual Health Summit , Lymphoma Society , American Cancer Society Action Network , Investigations Via Equitable Research Studies For Everyone , Prescription Drug User Fee Act , Trials Act , Cancer , Clinical Research , Clinical Trial , Congress , Food And Drug Administration , Health Sciences , Leukemia , Pharmaceutical Industry , Pharmaceuticals Policy , Dc , Leukemia Amp Lymphoma Society , Pdufa Date ,